These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 9028013
1. Identification of phospholipase A2 and neurotoxic activities in the venom of the New Guinean small-eyed snake (Micropechis ikaheka). Geh SL, Vincent A, Rang S, Abrahams T, Jacobson L, Lang B, Warrell D. Toxicon; 1997 Jan; 35(1):101-9. PubMed ID: 9028013 [Abstract] [Full Text] [Related]
2. Pharmacological characterization of mikatoxin, an alpha-neurotoxin isolated from the venom of the New-Guinean small-eyed snake Micropechis ikaheka. Nirthanan S, Gao R, Gopalakrishnakone P, Gwee MC, Khoo HE, Cheah LS, Manjunatha Kini R. Toxicon; 2002 Jul; 40(7):863-71. PubMed ID: 12076639 [Abstract] [Full Text] [Related]
3. Phospholipase A2-dependent effects of the venom from the New Guinean small-eyed snake Micropechis ikaheka. Kuruppu S, Isbister GK, Hodgson WC. Muscle Nerve; 2005 Jul; 32(1):81-7. PubMed ID: 15803483 [Abstract] [Full Text] [Related]
4. Combined venom gland cDNA sequencing and venomics of the New Guinea small-eyed snake, Micropechis ikaheka. Paiva O, Pla D, Wright CE, Beutler M, Sanz L, Gutiérrez JM, Williams DJ, Calvete JJ. J Proteomics; 2014 Oct 14; 110():209-29. PubMed ID: 25109465 [Abstract] [Full Text] [Related]
5. Preclinical efficacy of Australian antivenoms against the venom of the small-eyed snake, Micropechis ikaheka, from Papua New Guinea: an antivenomics and neutralization study. Pla D, Paiva OK, Sanz L, Beutler M, Wright CE, Calvete JJ, Williams DJ, Gutiérrez JM. J Proteomics; 2014 Oct 14; 110():198-208. PubMed ID: 24980637 [Abstract] [Full Text] [Related]
6. Presynaptic snake beta-neurotoxins produce tetanic fade and endplate potential run-down during neuromuscular blockade in mouse diaphragm. Wilson HI, Nicholson GM. Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov 14; 356(5):626-34. PubMed ID: 9402043 [Abstract] [Full Text] [Related]
7. Neuromuscular action of venom from the South American colubrid snake Philodryas patagoniensis. Carreiro da Costa RS, Prudêncio L, Ferrari EF, Souza GH, de Mello SM, Prianti Júnior AC, Ribeiro W, Zamunér SR, Hyslop S, Cogo JC. Comp Biochem Physiol C Toxicol Pharmacol; 2008 Jul 14; 148(1):31-8. PubMed ID: 18455482 [Abstract] [Full Text] [Related]
8. The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle. Fatehi M, Rowan EG, Harvey AL, Harris JB. Toxicon; 1994 Dec 14; 32(12):1559-72. PubMed ID: 7725325 [Abstract] [Full Text] [Related]
9. Structure and function comparison of Micropechis ikaheka snake venom phospholipase A2 isoenzymes. Lok SM, Gao R, Rouault M, Lambeau G, Gopalakrishnakone P, Swaminathan K. FEBS J; 2005 Mar 14; 272(5):1211-20. PubMed ID: 15720395 [Abstract] [Full Text] [Related]
10. Search for a "toxic site" in snake venom phospholipases A2. Arriagada E, Cid H. Arch Biol Med Exp; 1989 Jul 14; 22(2):97-105. PubMed ID: 2515808 [Abstract] [Full Text] [Related]
11. Acetylcholine receptor binding characteristics of snake and cone snail venom postsynaptic neurotoxins: further studies with a non-radioactive assay. Stiles BG. Toxicon; 1993 Jul 14; 31(7):825-34. PubMed ID: 8212028 [Abstract] [Full Text] [Related]
12. alpha-Bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin and erabutoxin-b do not affect [3H]acetylcholine release from the rat isolated left hemidiaphragm. Apel C, Rícný J, Wagner G, Wessler I. Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec 14; 352(6):646-52. PubMed ID: 9053737 [Abstract] [Full Text] [Related]
13. The effects of two phospholipase A2 inhibitors on the neuromuscular blocking activities of homologous phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake. Fatehi M, Rowan EG, Harvey AL. Toxicon; 1995 Dec 14; 33(12):1633-43. PubMed ID: 8866620 [Abstract] [Full Text] [Related]
14. Cardiovascular, haematological and neurological effects of the venom of the Papua New Guinean small-eyed snake (Micropechis ikaheka) and their neutralisation with CSL polyvalent and black snake antivenoms. Tibballs J, Kuruppu S, Hodgson WC, Carroll T, Hawdon G, Sourial M, Baker T, Winkel K. Toxicon; 2003 Nov 14; 42(6):647-55. PubMed ID: 14602120 [Abstract] [Full Text] [Related]
15. Bovine serum albumin does not completely block synaptosomal cholinergic activities of presynaptically acting snake venom phospholipase A2 enzymes. Fletcher JE, Storella RJ, Jiang MS. Toxicon; 1995 Aug 14; 33(8):1051-60. PubMed ID: 8533139 [Abstract] [Full Text] [Related]
16. Neurotoxic activity of venom from the Australian eastern mouse spider (Missulena bradleyi) involves modulation of sodium channel gating. Rash LD, Birinyi-Strachan LC, Nicholson GM, Hodgson WC. Br J Pharmacol; 2000 Aug 14; 130(8):1817-24. PubMed ID: 10952670 [Abstract] [Full Text] [Related]
17. The facilitatory actions of snake venom phospholipase A(2) neurotoxins at the neuromuscular junction are not mediated through voltage-gated K(+) channels. Fathi H B, Rowan EG, Harvey AL. Toxicon; 2001 Dec 14; 39(12):1871-82. PubMed ID: 11600150 [Abstract] [Full Text] [Related]
18. Biological activities of Leptodeira annulata (banded cat-eyed snake) venom on vertebrate neuromuscular preparations. Torres-Bonilla KA, Schezaro-Ramos R, Floriano RS, Rodrigues-Simioni L, Bernal-Bautista MH, Alice da Cruz-Höfling M. Toxicon; 2016 Sep 01; 119():345-51. PubMed ID: 27390040 [Abstract] [Full Text] [Related]
19. Neurotoxins with phospholipase A2 activity in snake venoms. Chang CC. Proc Natl Sci Counc Repub China B; 1985 Apr 01; 9(2):126-42. PubMed ID: 2996044 [No Abstract] [Full Text] [Related]
20. Comparative electrophysiological characterization of ammodytoxin A, a β-neurotoxin from the nose-horned viper venom, and its enzymatically inactive mutant. Žužek MC, Ivanušec A, Herman J, Šribar J, Leonardi A, Frangež R, Križaj I. Toxicon; 2024 Aug 28; 247():107833. PubMed ID: 38942241 [Abstract] [Full Text] [Related] Page: [Next] [New Search]